Suchergebnisse - "Gupta, Neeraj"

PubPharm (4)

1

Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma

enthalten in: British journal of haematology | 2017

von Kumar, S. | Moreau, P. | Hari, P. | +17

2

Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma : China Continuation study

enthalten in: Journal of hematology & oncology | 2017

von Hou, J. | Jin, J. | Xu, Y. | +18

3

Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma : a phase 1 study

enthalten in: Journal of hematology & oncology | 2015

von Gupta, N. | Goh, Y. | Min, C. | +10

4

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma : an open-label phase 1/2 study

enthalten in: The Lancet. Oncology | 2014

von Kumar, S. | Berdeja, J. | Niesvizky, R. | +16

CommentIn: Lancet Oncol. 2014 Dec;15(13):1417-8. - PMID 25456357

1
[1]